Quantitation of IgG subclass antibody responses after immunization with a group B meningococcal outer membrane vesicle vaccine, using monoclonal mouse-human chimeric antibodies as standards

This publication has 21 references indexed in Scilit:

• Opsonophagocytic Activity Induced by Chimeric Antibodies of the Four Human IgG Subclasses With or Without Help from Complement
  Scandinavian Journal of Immunology, 1994
• Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
  The Lancet, 1991
• Human IgG subclass pattern of inducing complement‐mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration
  European Journal of Immunology, 1991
• Enhancement of Complement Activation and Cytolysis of Human IgG3 by Deletion of Hinge Exons
  Scandinavian Journal of Immunology, 1990
• Replacing the complementarity-determining regions in a human antibody with those from a mouse
  Nature, 1986
• Meningococcal disease in Norway
  Antonie van Leeuwenhoek, 1986
• Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: Results of an IUIS/WHO collaborative study
  Immunology Letters, 1985
• Quantitation of antigen-specific immunoglobulin G in human serum *1, *2II. Comparison of radioimmunoprecipitation and solid-phase radioimmunoassay techniques for measurement of immunoglobulin G specific for a complex allergen mixture (yellow jacket venom)
  Journal of Allergy and Clinical Immunology, 1981
• Protection against group B meningococcal disease. I. Comparison of group-specific and type-specific protection in the chick embryo model.
  The Journal of Experimental Medicine, 1976
• HUMAN IMMUNITY TO THE MENINGOCOCCUS
  The Journal of Experimental Medicine, 1969